Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Liquid Supplement/Beverage Guidance Defines Distinctions

This article was originally published in The Tan Sheet

Executive Summary

The CFSAN guidance goes into greater detail on distinguishing liquid supplements from beverages, addressing stakeholders’ complaint about a 2009 draft. “This tends to really draw a bright line between the two different categories,” says CRN Regulatory Counsel Rend Al-Mondhiry.

You may also be interested in...



Dr. Oz Grilling In Senate Tops 2014 Dietary Supplement News

Articles on the potential that debate around the benefits of fish oils will damage consumer regard for omega-3 supplements, FDA’s guidance on distinguishing between liquid supplements and conventional beverages and Daniel Fabricant’s exit from FDA’s supplement regulation office also were highly read in 2014.

Dr. Oz Grilling In Senate Tops 2014 Dietary Supplement News

Articles on the potential that debate around the benefits of fish oils will damage consumer regard for omega-3 supplements, FDA’s guidance on distinguishing between liquid supplements and conventional beverages and Daniel Fabricant’s exit from FDA’s supplement regulation office also were highly read in 2014.

Relaxation Potion Warning: Wake Up Call About FDA Beverage Guidance

FDA warning letter on Dewmar’s Lean Slow Motion…Potion line is the first addressing differences between products marketed as conventional beverages and as liquid supplements since a final guidance in January. Attorney Justin Prochnow says the warning could signal an FDA crackdown on melatonin in conventional beverages.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS107044

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel